TSHA Taysha Gene Therapies, Inc.
$5.02▼ -2.71%
Healthcare
Other
After hours
$5.02▲ +0.00%
Sep 11, 7:58 PM ET
Volume 1.78M
Avg Volume (10D) 2.05M
Key Metrics & Fundamentals
Market Cap
$1.64B
P/E Ratio
–
Div Yield
–%
52W Range
2.71 - 7.30
% vs 50 MA
-15.63%
% vs 200 MA
-8.09%
RSI-14
30.2
MACD Histogram
-0.0900
Beta (1Y vs SPY)
1.81
Free Cash Flow
-$40.42M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$49.78M
COGS
–
Operating Exp
$50.78M
Operating Income
-$50.78M
EBIT
-$50.78M
Pretax Income
-$46.64M
Net Income
-$46.64M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
These 3 Risky Stocks Could Be Sitting on 100% Upside
MarketBeat · Sep 7, 2026 3:35 PM
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 12:00 PM
Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call
Motley Fool · Aug 18, 2026 11:13 PM
Taysha Gene Therapies (TSHA) After Rett Trial Progress And Catalent Expansion Is The Undervalued Case Stronger
Simply Wall St. · Aug 13, 2026 2:09 PM
Taysha Gene Therapies, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 12:30 PM
Taysha Gene Therapies Inc (TSHA) (Q2 2026) Earnings Call Highlights: Rett Syndrome Program ...
GuruFocus.com · Aug 12, 2026 5:02 AM
Taysha Gene Therapies Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 1:04 AM
Taysha Gene Therapies Q2 Loss Widens
MT Newswires · Aug 11, 2026 8:56 PM
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 11, 2026 8:00 PM
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
GlobeNewswire · Aug 4, 2026 8:00 PM
Financial Overview - Income Statement
Quarterly
Dec 2025
See TSHA's money flow as a full page
Social Sentiment
No Reddit posts found for TSHA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.